SynthesisMedicine2019

Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Miao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.